Mon - Fri: 9:00 AM - 6:00 PM Contact Us
Vamsi Labs Ltd - Solapur

Vamsi Labs Ltd - Solapur

Solapur, Maharashtra Est. 1991

About Company

Description
VAMSI LABS LTD.an ISO 9001:2015, ISO 14001:2015 and ISO 45001:2018 company, is one of the major manufacturers of Active Pharmaceutical Ingredients (API's) in India. The factory is located in the industrial area of Solapur, Maharashtra, India. Anti-asthmatic (respiratory), Anti-Migraine and Anti-Psychotic API's are the main products. Today 60% of the sales are from antiasthma products.

Contact Information

Primary Phone
Primary phone
Secondary Phone
Secondary phone
Primary Email
Primary email
Secondary Email
Secondary email
Sales Email
Sales email

Registered Address

Full Address
A-14, A-15, A-31, A-32 & A-33, MIDC Area, Chincholi
City
Solapur
State
Maharashtra
Pincode
413255
Country
India

Business Information

Business Types
Manufacturer API Supplier Exporter
Year Established
1991
Manufacturing Units
1

Legal & Compliance

Certifications & Approvals

WHO-GMP
Not Certified
ISO
Not Certified
GMP
Not Certified
FSSAI
Not Certified
USFDA
Not Approved
EU-GMP
Not Certified
UK-MHRA
Not Approved
WHO Prequalified
No

PCD/Franchise Information

PCD Franchisor
No

Products

Total products: 12

Product Name Dosage Form Composition Therapeutic Category
(9-isopropyl-9-azabicyclo[3,3,1]non-3-yl)methanol - IPRATROPIUM BROMIDE -
(9-isopropyl-9-azabicyclo[3,3,1]non-3-yl)methanol - IPRATROPIUM BROMIDE -
4-Oxo-2-Phenylbutanoic acid - IPRATROPIUM BROMIDE -
4-Oxo-2-Phenylbutanoic acid - IPRATROPIUM BROMIDE -
Methyl 2, 2-dithienyl glycolate (Methyl Glycolate) - TIOTROPIUM BROMIDE -
Methyl 2, 2-dithienyl glycolate (Methyl Glycolate) - TIOTROPIUM BROMIDE -
MORE TABS EVENTS STATUTORY SECTION REPORT DIRECTOR REPORT EC-Approved Letter Six Monthly compliance report Six Monthly Report 6 monthly compliance report Oct 2022 to March 2023 33rd Annual Report 2022 Tablet - -
MORE TABS EVENTS STATUTORY SECTION REPORT DIRECTOR REPORT EC-Approved Letter Six Monthly compliance report Six Monthly Report 6 monthly compliance report Oct 2022 to March 2023 33rd Annual Report 2022 Tablet - -
N-Isopropyl Noratropine (IPT-II) - IPRATROPIUM BROMIDE -
N-Isopropyl Noratropine (IPT-II) - IPRATROPIUM BROMIDE -
Scopine-DI, 2-dithienyl glycolate (Scopine ester) - TIOTROPIUM BROMIDE -
Scopine-DI, 2-dithienyl glycolate (Scopine ester) - TIOTROPIUM BROMIDE -

Social Media

Company Status

Status
Active
Verification
Verified

Statistics

Profile Views
87
Total Inquiries
0
Quick Contact
Primary phone
Primary email
Compare (0/4)